Are GLP-1 receptor agonists gerotherapeutics or just treatments for obesity?

Nature Aging · Published 2026-06-22 · DOI 10.1038/s43587-026-01165-4

Authors (1)

James G. Peyer

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Peyer, J. (2026). Are GLP-1 receptor agonists gerotherapeutics or just treatments for obesity?. Nature Aging. https://doi.org/10.1038/s43587-026-01165-4

Related articles

• Senescent cells cluster CTCF on nuclear speckles to instruct an alternative splicing program · Nature Aging · 2026 · Same journal
• Tissue softness unlocks regeneration · Nature Aging · 2026 · Same journal
• Targeting interleukin-11 to slow ovarian aging · Nature Aging · 2026 · Same journal
• A need for pragmatism in preclinical aging and longevity research · Nature Aging · 2026 · Same journal
• An open competition for biomarkers of aging · Nature Aging · 2026 · Same journal
• Mapping and manipulating aged and senescent microglia · Nature Aging · 2026 · Same journal
• Spatial mapping and senolytic targeting of senescent and disease-associated microglia in aged mouse brain white matter · Nature Aging · 2026 · Same journal
• Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset · Nature Aging · 2026 · Same journal
• Questions of the future in aging and longevity research at the GIMM Festival · Nature Aging · 2026 · Same journal
• Spatiotemporal dynamics of tau extent and load increase in Alzheimer’s disease across four longitudinal cohorts · Nature Aging · 2026 · Same journal